Gowrisankar Rajam

Author PubWeight™ 10.85^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.	J Infect Dis	2010	1.35
2	E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae.	Microb Pathog	2007	1.28
3	Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines.	Clin Vaccine Immunol	2012	1.06
4	Adherence of recombinant pneumococcal surface adhesin A (rPsaA)-coated particles to human nasopharyngeal epithelial cells for the evaluation of anti-PsaA functional antibodies.	Vaccine	2006	0.98
5	Evaluation of a novel therapeutic approach to treating severe pneumococcal infection using a mouse model.	Clin Vaccine Immunol	2009	0.97
6	Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.	Antimicrob Agents Chemother	2011	0.92
7	Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae.	Clin Diagn Lab Immunol	2005	0.91
8	P4-mediated antibody therapy in an acute model of invasive pneumococcal disease.	J Infect Dis	2012	0.90
9	P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis.	Clin Vaccine Immunol	2010	0.88
10	Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model.	Vaccine	2010	0.83
11	Augmented Passive Immunotherapy with P4 Peptide Improves Phagocyte Activity in Severe Sepsis.	Shock	2016	0.78
12	Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations.	Antimicrob Agents Chemother	2013	0.76